Edlund M, Blombäck M, von Schoultz B, Andersson O
Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.
Am J Hematol. 1996 Dec;53(4):234-8. doi: 10.1002/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z.
The value of menorrhagia as a predictor for mild bleeding disorders has been very little studied and the results are divergent. In the present study on 30 women with objectively verified menorrhagia, we found a significantly increased prevalence of von Willebrand's disease (20%). By keeping a strict sampling and laboratory routine, and by restricting sampling to cycle days 5-7, we also obtained a very low interindividual variation of von Willebrand factor and coagulation factor VIII. We conclude that menorrhagia is a valuable predictor for coagulation and platelet disorders, and that time of sampling is of importance. This should be considered in the investigation of menorrhagia, and can be a guideline in looking for mild bleeding disorders.
月经过多作为轻度出血性疾病预测指标的价值鲜有人研究,且结果不一。在本项针对30名经客观证实月经过多的女性的研究中,我们发现血管性血友病的患病率显著增加(20%)。通过严格遵循采样和实验室操作规范,并将采样限制在月经周期的第5 - 7天,我们还获得了血管性血友病因子和凝血因子VIII极低的个体间变异。我们得出结论,月经过多是凝血和血小板疾病的一个有价值的预测指标,且采样时间很重要。在月经过多的调查中应考虑这一点,它可作为寻找轻度出血性疾病的指导原则。